HRV Chart for Females by Age
Heart rate variability differs between sexes, with females generally showing slightly lower SDNN but comparable or higher RMSSD values than males in younger age groups. Hormonal fluctuations across the menstrual cycle, pregnancy, and menopause significantly influence female HRV patterns. This chart provides female-specific normative HRV ranges based on published sex-stratified population data.
Reference Data
| Age Range | RMSSD Normal Range (ms) | SDNN Normal Range (ms) |
|---|---|---|
| 20–25 | 24–100(24–100) | 36–112(36–112) |
| 25–30 | 22–92(22–92) | 34–108(34–108) |
| 30–35 | 19–82(19–82) | 32–102(32–102) |
| 35–40 | 16–74(16–74) | 29–96(29–96) |
| 40–45 | 14–66(14–66) | 27–90(27–90) |
| 45–50 | 12–58(12–58) | 25–85(25–85) |
| 50–55 | 10–50(10–50) | 22–80(22–80) |
| 55–60 | 9–44(9–44) | 20–75(20–75) |
| 60–65 | 8–40(8–40) | 18–70(18–70) |
| 65–70 | 7–36(7–36) | 16–66(16–66) |
| 70–75 | 6–32(6–32) | 14–62(14–62) |
| 75+ | 5–28(5–28) | 12–58(12–58) |
Source: Koenig & Thayer, 2016, PLoS ONE; Voss et al., 2015, Heart Rhythm; ESC Task Force on HRV, 1996, Circulation; Snieder et al., 2007, Twin Research and Human Genetics.
How to Interpret This Data
Female HRV is influenced by unique physiological factors not present in males. During the menstrual cycle, HRV is typically highest in the follicular phase (days 1–14) when estrogen is dominant, and lowest during the luteal phase (days 15–28) when progesterone increases sympathetic tone. This cyclical variation can cause RMSSD to fluctuate by 10–20% within a single month, making it important to compare measurements taken at the same cycle phase.
Menopause is associated with a significant decline in HRV beyond what is expected from aging alone. The loss of estrogen's cardioprotective and vagotonic effects leads to an accelerated HRV decline typically beginning in the perimenopausal period (ages 45–55). Hormone replacement therapy has been shown in some studies to partially attenuate this decline, though the evidence remains mixed. Pregnancy also substantially alters HRV, with a progressive decrease in parasympathetic tone from the first to third trimester.
When interpreting female HRV, consider cycle phase, menopausal status, hormonal contraceptive use, and pregnancy status. Oral contraceptives can reduce HRV by suppressing the natural hormonal fluctuations that modulate vagal tone. These ranges represent general population norms for healthy females; individual targets should account for fitness level, body composition, and overall cardiovascular health. Consult a healthcare provider if HRV is persistently below the lower range for your age.
Frequently Asked Questions
Is HRV different for women compared to men?
Yes. Younger women (under 30) tend to have similar or slightly higher RMSSD values than men due to greater vagal tone, but SDNN values are typically slightly lower. After menopause, female HRV often declines more sharply than male HRV of the same age due to the loss of estrogen's cardioprotective effects. Menstrual cycle phase also creates cyclical HRV variations unique to premenopausal women.
Does the menstrual cycle affect HRV readings?
Yes, significantly. HRV is typically 10–20% higher during the follicular phase (days 1–14) compared to the luteal phase (days 15–28). For accurate trend tracking, compare HRV readings taken at the same phase of your cycle, or use a 30-day rolling average to smooth out cyclical variation.
How does menopause affect heart rate variability?
Menopause leads to an accelerated decline in HRV beyond normal aging. The drop in estrogen reduces parasympathetic tone and baroreflex sensitivity. Studies show perimenopausal and postmenopausal women have 15–25% lower RMSSD compared to premenopausal women of similar age. Regular aerobic exercise is the most evidence-supported intervention to maintain HRV through this transition.